Animal Pharm is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Financial Results

Set Alert for Financial Results

Latest From Financial Results

ImmuCell shares fall to two-year low following weak Q2

US company ImmuCell has seen its share price drop to its lowest level since 2017.

Financial Results

Covetrus price plummets following underwhelming Q2

Covetrus shares have fallen to their lowest value since the company started trading on the stock market earlier this year.

Financial Results

Benchmark could see sales hit in third quarter

UK aquaculture health firm Benchmark is continuing to face challenges in the global shrimp and Mediterranean seabass/bream markets.

Aquaculture Financial Results

Covetrus posts flat Q2, anticipates 'low single-digit' growth for 2019

Covetrus has posted sales of around $1 billion for the second quarter of 2019, representing a flat year-on-year comparison.

Financial Results Operations

Elanco Q2 sales bugged by currency exchange, no mention of Bayer deal

Elanco's second-quarter revenues have been impacted by foreign currency exchange rates and the firm has scaled back its full-year forecast due to African swine fever (ASF).

Elanco Financial Results

ImmuCell Q2 hit by order backlogs, net loss still declining

ImmuCell has seen its sales drop in Q2 2019, after previously recording its "best quarter ever". 

Financial Results Operations
See All